← European Medicine Shortage Tracker · all medicines

Axitinib shortage — availability across Europe

Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.

MEDICALLY REVIEWED
Dr. Chrysoula I. Liakou MD, PhD
Internal Medicine Specialist
Cancer Immunology Researcher
Reviewed 30 July 2026 · next review due 30 January 2027

Axitinib currently has availability issues reported in 3 European registers: Spain, Greece, Italy.

Shortage  ATC L01EK01 · also listed as: AXITINIB · data refreshed 11 September 2026

Key facts

As of 11 September 2026, 3 of the 9 tracked registers list current availability issues for Axitinib, covering 3 affected product presentations. The longest-running open report was filed in Italy on 2026-02-09 and has now been open for about 7 months. Where agencies state a cause, unexpectedly high demand lead with 1 of the 1 stated-cause reports. The furthest expected-resolution date currently on file is 2026-10-26; the earliest is 2026-10-22. Momentum is current, not historical: 2 of the open reports were filed within the last 90 days. The issue spread across registers over time rather than at once: Italy reported first (2026-02-09), with Spain following roughly 6 months later — a pattern typical of supply problems cascading between national markets. Registers in Spain, Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Axitinib is coded L01EK01 — a medicine acting on antineoplastic and immunomodulating agents — so clinically related products appear under “Related medicines” below.

WhereStatus & productsSinceExpected end Reason / alternativesSource
🇪🇸 SpainShortage
AXITINIB TEVA 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 56 comprimidos
2026-08-232026-10-22Existen otros medicamentos con el mismo principio activo y misma vía.
Alternatives: Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración.
register ↗
🇬🇷 GreeceLimited availability
OPA/AL/PVC/AL BLISTERS
2026-08-172026-10-26Αυξημένη ζήτηση περιεκτικότητας Εναλλακτικά το ίδιο φάρμακο διαφορετικregister ↗
🇮🇹 ItalyShortage
AXITINIB SANDOZ
2026-02-09Elevata richiesta
Alternatives: AIFA: equivalents with the same active substance are available.
register ↗
🇸🇪 SwedenDiscontinued
Axitinib Teva 1 mg Filmdragerad tablett
2028-04-30
Alternatives: Alternative(s) available — see the national register.
register ↗

New register reports per month

2026-02: 12026-03: 02026-04: 02026-05: 02026-06: 02026-07: 02026-08: 22026-022026-08

Full report history (4 register entries)

Every individual register entry for Axitinib in the tracked sources, newest first — including resolved and discontinued reports.

Reg.ProductStatusReportedExpected endStated reason
🇸🇪 SEAxitinib Teva 1 mg Filmdragerad tablettDiscontinued2028-04-30
🇪🇸 ESAXITINIB TEVA 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 56 compriShortage2026-08-232026-10-22Existen otros medicamentos con el mismo principio activo y m
🇬🇷 GROPA/AL/PVC/AL BLISTERSLimited availability2026-08-172026-10-26Αυξημένη ζήτηση περιεκτικότητας Εναλλακτικά το ίδιο φάρμακο
🇮🇹 ITAXITINIB SANDOZShortage2026-02-09Elevata richiesta

Frequently asked

Is Axitinib currently in shortage in Europe?

Yes. As of 11 September 2026, availability issues are reported in: Spain, Greece, Italy. Availability is national — a shortage in one country does not mean it is short everywhere.

When is the Axitinib shortage expected to end?

Agency prognoses on file range from 2026-10-22 to 2026-10-26. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.

Are there alternatives to Axitinib?

2 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.

Where does this Axitinib availability data come from?

Directly from the official medicines-agency registers that list Axitinib: AEMPS CIMA (Spain), EOF limited-availability list (Greece), AIFA (Italy), Läkemedelsverket (Sweden). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Related medicines (same ATC class)

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Axitinib — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/axitinib/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Axitinib availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/axitinib/">Axitinib shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>
Cite: “Axitinib: availability status across 4 European registers — European Medicine Shortage Tracker (MobiDoctor), 11 September 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.